Clinical profile of dengue hemorrhagic fever cases in Mexico

Navarrete-Espinosa, Joel; Gómez–Dantés, Héctor; Celis-Quintal, Juan Germán; Vázquez-Martínez, José Luis

doi:10.1590/s0036-36342005000300002

Cited by 31 publications

(20 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The percentage of DENV-4 isolates was less than 1% in 2009 and 2010 [26]. For the period 1995–2003, Navarette-Espinosa et al reported that 9% of isolates were DENV-1, 60% were DENV-2, and 31% were DENV-3 (there were no DENV-4 isolates) [33].…”

Section: Resultsmentioning

confidence: 99%

Epidemiological Trends of Dengue Disease in Mexico (2000–2011): A Systematic Literature Search and Analysis

2014

View full text Add to dashboard Cite

This systematic literature review describes the epidemiology of dengue disease in Mexico (2000–2011). The annual number of uncomplicated dengue cases reported increased from 1,714 in 2000 to 15,424 in 2011 (incidence rates of 1.72 and 14.12 per 100,000 population, respectively). Peaks were observed in 2002, 2007, and 2009. Coastal states were most affected by dengue disease. The age distribution pattern showed an increasing number of cases during childhood, a peak at 10–20 years, and a gradual decline during adulthood. All four dengue virus serotypes were detected. Although national surveillance is in place, there are knowledge gaps relating to asymptomatic cases, primary/secondary infections, and seroprevalence rates of infection in all age strata. Under-reporting of the clinical spectrum of the disease is also problematic. Dengue disease remains a serious public health problem in Mexico.

show abstract

Section: Resultsmentioning

confidence: 99%

Epidemiological Trends of Dengue Disease in Mexico (2000–2011): A Systematic Literature Search and Analysis

2014

View full text Add to dashboard Cite

show abstract

“…On the other hand, regarding the clinical behavior, dengue is characterized by the presence of fever, headache, myalgia, arthralgia of variable intensity, and exanthema; this is accompanied by general malaise and other signs and symptoms that may or may not be present [15]- [17]. Characteristically, mild-intensity presentations are indistinguishable in many infectious diseases, and only severe cases of dengue may manifest differently through hemorrhages, capillary fragility data, or leak of liquids.…”

Section: Discussionmentioning

confidence: 99%

Clinical Behavior of Dengue and Chikungunya Infections in the Instituto Mexicano del Seguro Social

Navarrete-Espinosa¹,

González-Ibarra²,

Cruz-Tinoco³

et al. 2016

OJMM

Self Cite

View full text Add to dashboard Cite

Arbovirus infections have increased worldwide in the last years and specific differential diagnosis may be difficult owing to their similar clinical presentations. Here we describe and compare the clinical manifestations of dengue and chikungunya fever. Material and Methods: In order to portray the clinical behavior of both diseases, a cross-sectional study was performed including patients insured by the Mexican Institute for Social Security (IMSS), their demographic data, and clinical signs and symptoms. Laboratory parameters were analyzed. Results: One thousand four hundred and ninety-five dengue and 1810 chikungunya cases were studied. All patients presented fever, whereas headache, myalgias, mild arthralgias, and ocular pain were more frequent in dengue cases. Severe incapacitating polyarthralgias, arthritis, and conjunctivitis were present only in chikungunya cases. Also, edema and exanthema were more frequent in patients with chikungunya. Liquid leak to tissues and hemorrhage were more frequent among dengue cases. Platelet counts were lower in hemorrhagic dengue (P < 0.001). Laboratory parameters were altered between the second and third day of evolution and tended to return to normal from the fifth day. Discussion: The clinical features observed in this group of patients may contribute to the differential diagnosis of both diseases. The cardinal signs of severity were not present in all cases of any of the two diseases. It is important to consider these issues in order to establish an early diagnosis and improve the prognosis of patients. KeywordsChikungunya, Behavior, Clinical J. Navarrete-Espinosa et al. 24

show abstract

“…Approximately 82% of Vietnamese children in shock were correctly identified using the narrow WHO classification system 50 , although the tourniquet test had a sensitivity of only 41.6% 51 . Differences between disease patterns from Southeast Asia and the Americas can be traced to clinical practice, particularly to the failure of clinicians in the Americas to collect appropriate data to fulfil the requirements of the WHO case definition 52 . In Asia, better case management and intensive national programs to educate parents and medical staff improved early care and avoidance of over hydration of dengue hemorrhagic fever/dengue shock syndrome patients 43 .…”

Section: Health Services Determinants Clinical Profilementioning

confidence: 99%

Dengue in the Americas: challenges for prevention and control

Gómez–Dantés

Willoquet

2009

Cad. Saúde Pública

Self Cite

View full text Add to dashboard Cite

Dengue is the most important vector-borne disease in the Americas and threatens the lifes of millions of people in developing countries. Imprecise IntroductionDengue is now the most important vector-borne disease in the Americas and threatens the health of millions of people that live in urban, suburban and rural environments. Clinical and public health services have been unable to diminish this disease since there is no vaccine available to prevent infection, no effective medical treatments that avert the development of severe symptoms and no sustainable control measures against the vector that guarantee protection of affected communities.Dengue was initially identified as breakbone fever in 1790 in Philadelphia, U.S.A 1 , and later spread throughout the Americas, until the Pan American Health Organization (PAHO) launched an Aedes aegypti eradication campaign to combat yellow fever in the 1950s and 1960s that came close to eliminating the vector from the continent 2 . Although the geographical distribution of the vector is similar to its distribution before the eradication campaigns 3 , populations during the "eradication era" were principally rural. In the last 40 years, there has been intensive urbanization due to massive migration from agricultural areas to cities. Although urbanization in Latin America and the Caribbean had already reached 41% of the population by 1950, the population living in urban areas is expected to reach between 82 and 84% by 2030; by then the Latin America and Caribbean region will be the second most urbanized REVISÃO REVIEW Gómez-Dantés H, Willoquet JR S20 Cad. Saúde Pública, Rio de Janeiro,

show abstract

Clinical profile of dengue hemorrhagic fever cases in Mexico

Cited by 31 publications

References 18 publications

Epidemiological Trends of Dengue Disease in Mexico (2000–2011): A Systematic Literature Search and Analysis

Epidemiological Trends of Dengue Disease in Mexico (2000–2011): A Systematic Literature Search and Analysis

Clinical Behavior of Dengue and Chikungunya Infections in the Instituto Mexicano del Seguro Social

Dengue in the Americas: challenges for prevention and control

Contact Info

Product

Resources

About